Patient Adherence Programs Built for Specialty & Rare Disease Therapies
Patient Adherence Programs Built for Specialty & Rare Disease Therapies

Patient Adherence is a Significant Challenge for the US Healthcare Industry
45% of the American population has one or more chronic conditions that require medication, and starting and staying on these complex therapies isn’t easy.
1
OUT
OF
3
3
OUT
OF
4
69%
patients never start medication prescribed by their doctor
patients become non-adherent to their medications
of medication-related hospital admissions are due to poor adherence
Poor Patient Adherence is Due to Barriers Patients Face
Momentum Integrated Approach to Medication Adherence
Momentum has a digitally-integrated, human-centered approach to boosting medication adherence


Old Model
Human Only
Cannot expand to meet the demand; inefficient, inconsistent and expensive


Ineffective Model
Digital Only
Creates a divide between those who are comfortable and those who are not, and risks widening gaps in health equality and access
Foundational Elements of Momentum Patient Adherence Programs

Establish trust early on
Provide consistency of support
Build direct relationships with patients
Listen and learn from interventions
Make it convenient
Personalize all aspects
Keep it simple
Go beyond the medicine
Be empathetic
Incorporate a feedback loop to HCPs
Related Resources

Report
From Transactional to Transformational Patient Engagement
At the recent Informa Connect Patient Support Services Congress, Momentum Life Sciences led an industry panel discussion focused on advancing and elevating patient support. This month’s Patient Services Report distills the five key recommendations that pharma manufacturers can leverage to increase meaningful connection that drives adherence.

Report
Report: From Transaction to Transformational Patient Engagement
At the 2025 Patient Support Services Congress in Philadelphia, we examined how to safeguard patient engagement from transactional experiences. The panel shared practical insights on building empathetic, human-centered support models and leveraging technologies like AI to elevate—not diminish—the patient experience.

Report
Solving the Data Disconnect
A combined view of qualitative and quantitative data reveals what patients need, where support falls short, and how care teams can create more connected, effective experiences across the journey. Read our November Patient Services Report to explore how meaningful measurement can reshape patient support.

Report
Embracing a New Era of Drug Distribution
Pharma's DTC shift offers convenient access to therapies, but access alone isn't enough. Success requires pairing digital efficiency with meaningful human connection to help patients succeed on their treatment journeys. Learn more in our October Patient Services Report.


